Joke Collection Website - Public benefit messages - The latest news of inhaled COVID-19 vaccine in 2022: vaccine policy in COVID-19, Ningbo.

The latest news of inhaled COVID-19 vaccine in 2022: vaccine policy in COVID-19, Ningbo.

Ningbo inhales COVID-19 vaccine.

According to the unified deployment and requirements of Zhejiang Province, Ningbo has recently carried out inhalation COVID-19 vaccination in various districts. At present, Ningbo Haishu Baiyun Street Community Health Service Center has opened an appointment channel, and citizens can log in to Zhejiang to run APP to make an appointment for vaccination.

I. The appointment procedure is as follows

1. Log in to Li Zhe office APP and search for "vaccination". This step requires real-name registration!

2. Click "COVID-19 Vaccine"

3. Choose COVID-19 vaccine inhalation to confirm the vaccination time and outpatient service.

Two, Baiyun street vaccination information

Inoculation time

65438+February 8th afternoon: 14:00— 16:00.

65438+February 22nd afternoon: 14:00— 16:00.

65438+February 15 pm:14: 00-16: 00.

65438+February 29th afternoon: 14:00— 16:00.

Please go to "Li Zhe Office" APP to make an appointment for inhaled COVID-19 vaccine.

Inoculation target

1, only those who receive text messages.

2. "Li Zhe Office" successfully booked the crowd.

Inoculation site

Haishu district Baiyun neighbourhood community health service center sanlou prevention vaccination outpatient

consulting telephone

Tel:15858403121557 10 176.

Consultation time: every Monday to Friday from 7: 30 to 1 1: 30, 14: 00 to 17: 00.

skill

1. Please show your health code and green code to enter the medical institution.

2. Do not detect nucleic acid within 48 hours after vaccination in COVID-19.

Three, inhalation vaccination instructions

Inoculation target

65438+ susceptible population aged 08 and above who have completed basic immunization with specific vaccines for 6 months.

Vaccine action

Prevent novel coronavirus.

Inoculation procedure

* * * Inoculation 1 dose. 1 people aged 8 and above who have completed 2 doses of inactivated COVID-19 vaccine or intramuscular injection of 1 dose of recombinant COVID-19 vaccine within 6 months and have not been vaccinated with other COVID-19 vaccines can be vaccinated with1dose of this vaccine for supplementary immunization. Please consult your local vaccination unit for details.

Inoculation dose, location and route

0. 1ml, atomized and inhaled orally.

counteraction

Common adverse reactions: headache, fever, fatigue, cough, runny nose, sneezing, joint pain, dizziness, drowsiness, dry mouth and hoarseness.

2. Occasionally, there are adverse reactions: nausea, myalgia, diarrhea, loss of appetite, chest pain, itching, vomiting, rash, mucosal diseases, pharyngeal swelling, oropharyngeal pain and oropharyngeal discomfort.

3. Oral mucositis is rare.

Contraindications

1. Those who are allergic to active ingredients, any inactive ingredients and substances used in the production process of this product, or those who have been allergic to similar vaccines before.

2. People who had severe allergic reactions to vaccines in the past.

3. Patients with uncontrolled epilepsy and other progressive nervous system diseases have a history of Guillain-Barre syndrome.

Matters needing attention

1. You need to observe for 30 minutes after inoculation. Please don't leave early.

2. The protective effect of any vaccine cannot reach100%; A few people have no protection after vaccination, which is related to the characteristics of the vaccine itself and the personal physique of the recipients.

3. The following situations are regarded as inspiratory failure.

There is obvious misty gas in the atomizing cup after inhalation;

Cough and early expiration occur when inhaling. Suction failure requires another dose of vaccine, and repeated inhalation is only allowed once.

4. Use with caution in the following situations: acute disease, acute attack of chronic disease, severe chronic disease, allergic constitution and fever; Have a history or family history of convulsion, epilepsy, encephalopathy or mental illness; Have a history of asthma, chronic obstructive pulmonary disease, pulmonary fibrosis and other basic diseases or abnormal lung function.

5. The above contents shall be subject to the relevant provisions of the state and our province.